Certimab Control, S.L.

Certimab Control, S.L. discloses dealings in Alantra Partners, S.A. to CNMV. The record holds 41 filings, for trades running from 9 June 2023 to 9 July 2026.

Purchases make up the whole of the open-market record (29 purchases, €1.2M). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2026, the count stands at 9 purchases and no sales.

Half of the purchases are above €11k and half below. Relative to company size, the median is 0.0030% of market cap (29 purchases with a known value). Across 28 purchases, this insider has always bought alone, with no colleague buying within 30 days. Looking at 21 purchases old enough to measure, the stock rose over the following 90 days in 5% of cases; the median change was -9.1%. They describe history only and say nothing certain about the share price ahead.

Most recently, on 9 July 2026, the filings show a transaction in Alantra Partners, S.A. The last purchase on record was published on 27 May 2026, which is 144 days ago. Between a trade and the moment it shows up on CNMV, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). This summary is built from CNMV disclosures alone and does not predict where the share price will go.